BEGIN:VCALENDAR
VERSION:2.0
PRODID:talks.ox.ac.uk
BEGIN:VEVENT
SUMMARY:How are CD8+ T cell responses primed in humans? - Professor Rod Du
 nbar (The University of Auckland)
DTSTART;VALUE=DATE-TIME:20250616T120000
DTEND;VALUE=DATE-TIME:20250616T130000
UID:https://talks.ox.ac.uk/talks/id/91407b53-ee72-444e-a72f-dcd1b57bbb59/
DESCRIPTION:CD8+ T cells can recognise and kill virus-infected cells and c
 ancer cells. Understanding how they first recognise antigen\, then prolife
 rate and differentiate\, is crucial to improving the design of vaccines an
 d immunotherapy for viral infections and cancer.  The immunology canon tea
 ches us that a subset of dendritic cells (CLEC9A+ XCR1+ “DC1”) initiat
 es CD8+ T cell responses in lymph nodes.  However single cell and spatial 
 data from human lymphoid tissue suggest DC1 are unlikely to fulfil this ro
 le in humans.  What are the alternative scenarios for “priming” human 
 CD8+ T cells – and what are the implications for immune therapy?\nSpeake
 rs:\nProfessor Rod Dunbar (The University of Auckland)
LOCATION:Kennedy Institute of Rheumatology (Kennedy Lecture Theatre)\, Hea
 dington OX3 7FY
TZID:Europe/London
URL:https://talks.ox.ac.uk/talks/id/91407b53-ee72-444e-a72f-dcd1b57bbb59/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:How are CD8+ T cell responses primed in humans? - Profess
 or Rod Dunbar (The University of Auckland)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:Immunotherapy of melanoma: where to next? - Professor Rod Dunbar (
 The University of Auckland)
DTSTART;VALUE=DATE-TIME:20180706T130000
DTEND;VALUE=DATE-TIME:20180706T140000
UID:https://talks.ox.ac.uk/talks/id/a8f4e556-2557-4b79-b514-e45b99e6ae43/
DESCRIPTION:\nSpeakers:\nProfessor Rod Dunbar (The University of Auckland)
LOCATION:MRC Weatherall Institute of Molecular Medicine (WIMM Seminar Room
 )\, Headington OX3 9DS
TZID:Europe/London
URL:https://talks.ox.ac.uk/talks/id/a8f4e556-2557-4b79-b514-e45b99e6ae43/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:Immunotherapy of melanoma: where to next? - Professor Rod
  Dunbar (The University of Auckland)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR
